Publications - IR Sant Pau

Search

01/09/2024 Interobserver agreement in the visual analysis of brain PET/CT studies with Tau tracer [¹⁸F]PI-2620 in patients with Down syndrome.

Mormandi, PS, Ballester, PZ, Calls, M, Aguirre, SR, Leon, AF, Guzman, G, Lozano, CS, Castejon, S, Nu o, MV, Duch, J, Fortea, J, Camacho, V, Giralt, AF. Interobserver agreement in the visual analysis of brain PET/CT studies with Tau tracer [¹⁸F]PI-2620 in patients with Down syndrome.. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2024; 51DOI:. PMID:. IF:7.600(Q1/1D).

01/09/2024 Right ventricular dysfunction in the critically ill. Echocardiographic evaluation

Gutiérrez, VF, Fenor, LZ, Ortiz, AB, Mier, MG, Calvo, AO. Right ventricular dysfunction in the critically ill. Echocardiographic evaluation. Medicina Intensiva. 2024; 48(9)DOI:10.1016/j.medin.2024.05.008. PMID:39079775. IF:3.100(Q2/3D).

01/09/2024 Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

Gras-Martín, L, Plaza-Diaz, A, Zarate-Tamames, B, Vera-Artazcoz, P, Torres, OH, Bastida, C, Soy, D, Ruiz-Ramos, J. Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090801. PMID:39334976. IF:4.600(Q1/2D).

01/09/2024 Guide for the efficient and safe delivery of Telepharmacy

Collado-Borell, R, Gomis-Pastor, M, Rodríguez-Cabezas, M, Parro-Martín, A, Linares-Alarcón, A, Gutiérrez, E, González-Corominas, E, Fernández-Polo, A, Domínguez-Cantero, M, Arrondo-Velasco, A, Morillo-Verdugo, R. Guide for the efficient and safe delivery of Telepharmacy. Health Policy and Technology. 2024; 13(4)DOI:10.1016/j.hlpt.2024.100899. PMID:. IF:3.700(Q1/1D).

01/09/2024 A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study

Puig, L, Belloso, RI, Rivera-Díaz, R, Sánchez, JM, Fernández-Freire, LR, Sahuquillo-Torralba, A, Ruiz-Villaverde, R. A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study. DERMATOLOGY. 2024; 240(5-6)DOI:10.1159/000540019. PMID:39019021. IF:2.700(Q2/4D).

01/09/2024 Safety in Patients with Latent Tuberculosis Who Received Concomitant Anti-Tuberculosis Medications: Analysis of 11 Studies of Guselkumab in Psoriatic Disease

Puig, L, Tsai, TF, Soriano, ER, Bhutani, T, Miller, M, Kollmeier, AP, Li, S, You, Y, Petrick, M, Li, HW, Patel, H, Lavie, F, Gooderham, M, Londo o, A, Lebwohl, M, Nash, P. Safety in Patients with Latent Tuberculosis Who Received Concomitant Anti-Tuberculosis Medications: Analysis of 11 Studies of Guselkumab in Psoriatic Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension

Tha i, D, Puig, L, Merola, JF, Jullien, D, Costanzo, A, Wang, M, Deherder, D, Pinto, JML, Lebwohl, M. Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions

Ständer, S, Pereira, MP, Zeidler, C, Legat, FJ, Misery, L, Loenndahl, L, Bewley, AP, Brenaut, E, Bobko, S, Elberling, J, Evers, AWM, Garcovich, S, Gieler, U, Goncalo, M, Kupfer, J, Lambert, J, Lvov, A, Metz, M, Michenko, A, Papadavid, E, Reich, A, Savk, E, Schneider, G, Schut, C, Serra-Baldrich, E, Ständer, HF, Szepietowski, JC, Wallengren, J, Weisshaar, E, Augustin, M. EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(9)DOI:10.1111/jdv.20102. PMID:38738586. IF:8.000(Q1/1D).

01/09/2024 Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial

Garcia-Ruiz, A, Macarro, C, Zacchi, F, Morales-Barrera, R, Grussu, F, Casanova-Salas, I, Sanguedolce, F, Gonzalez, M, Cresta-Morgado, P, de Albert, M, Garcia-Bennett, J, Marmolejo, D, Planas, J, Roche, S, Mast, R, Zatse, C, Piulats, JM, Herrera-Imbroda, B, Regis, L, Agundez, L, Olmos, D, Calvo, N, Escobar, M, Carles, J, Mateo, J, Perez-Lopez, R. Whole-body Magnetic Resonance Imaging as a Treatment Response Biomarker in Castration-resistant Prostate Cancer with Bone Metastases: The iPROMET Clinical Trial. EUROPEAN UROLOGY. 2024; 86(3)DOI:10.1016/j.eururo.2024.02.016. PMID:38490857. IF:25.200(Q1/1D).

01/09/2024 Comparing thulium fiber versus high power holmium laser in bilateral same sitting retrograde intrarenal surgery for kidney stones: Results from a multicenter study

Chai, CA, Inoue, T, Somani, BK, Yuen, SKK, Ragoori, D, Gadzhiev, N, Tanidir, Y, Emiliani, E, Bin Hamri, S, Lakmichi, MA, Chandramohan, V, Naselli, A, Soebhali, B, Gokce, MI, Tursunkulov, AN, Chillón, FRD, Chew, B, Traxer, O, Castellani, D, Gauhar, V. Comparing thulium fiber versus high power holmium laser in bilateral same sitting retrograde intrarenal surgery for kidney stones: Results from a multicenter study. Investigative and Clinical Urology. 2024; 65(5)DOI:10.4111/icu.20240185. PMID:39249917. IF:2.100(Q2/5D).

01/09/2024 Current Perspectives on Endourological Ex Vivo Stone Interventions in Kidney Transplantation: A Systematic Review

Haberal, HB, Tonyali, S, Piana, A, Keller, EX, Sierra, A, Marco, BB, Tzelves, L, Pecoraro, A, Esperto, F, López-Abad, A, Prudhomme, T, Campi, R, Boissier, R, Pietropaolo, A, Breda, A, Territo, A. Current Perspectives on Endourological Ex Vivo Stone Interventions in Kidney Transplantation: A Systematic Review. UROLOGY. 2024; 191DOI:10.1016/j.urology.2024.06.005. PMID:38878828. IF:2.000(Q2/5D).

01/09/2024 Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery

Fa-Binefa, M, Rojas-Sayol, R, Peiró, A, Trullols, L, Machado, P, Gracia, I. Metal Ion Release in Cancer Patients Following Megaprosthesis Salvage Surgery. JOURNAL OF ARTHROPLASTY. 2024; 39(9)DOI:10.1016/j.arth.2024.04.034. PMID:38640965. IF:3.800(Q1/2D).

01/09/2024 Reply to Maelle El Kefi, Philippe A. Liverneaux: Is ultrasound superior to fluoroscopy in distal radius volar fixation?

Toro-Aguilera, A, Arenas-Romera, J, Carrera, I, Lamas, C. Reply to Maelle El Kefi, Philippe A. Liverneaux: Is ultrasound superior to fluoroscopy in distal radius volar fixation?. Hand Surgery & Rehabilitation. 2024; 43(4)DOI:10.1016/j.hansur.2024.101763. PMID:39187066. IF:1.000(Q3/8D).

01/09/2024 Clavipectoral fascia plane block in midshaft clavicle fractures: A cadaveric study

Labandeyra, H, Heredia, C, Váldes-Vilches, LF, Prats-Galino, A, Sala-Blanch, X. Clavipectoral fascia plane block in midshaft clavicle fractures: A cadaveric study. JOURNAL OF CLINICAL ANESTHESIA. 2024; 96DOI:10.1016/j.jclinane.2024.111469. PMID:38678917. IF:5.100(Q1/1D).

01/09/2024 Cryobiopsy guided by electromagnetic navigation bronchoscopy for the diagnosis of peripheral lung nodules

Rafecas-Codern, A, Otero, AP, Colom, MN, Castosa, MV, Mitja, PS, Fernadez, AT, Ruiz, VP. Cryobiopsy guided by electromagnetic navigation bronchoscopy for the diagnosis of peripheral lung nodules. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1628. PMID:. IF:21.000(Q1/1D).

01/09/2024 Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis

Garc a-Alija, A, Park, HS, Moya, P, Laiz, A, Marco, C, Casals, A, Pitarch, C, Diaz-Torn , C, Magallares, BP, Barranco, IC, Fern ndez-S nchez, S, Garc a-Guillen, A, Tandaipan, JL, Codes-Mendez, H, Verdaguer, G, Sainz, L, Corominas, H. Disease Duration, Age and Clinical Features Related to Aortic Valve Sclerosis in Patients with Spondyloarthritis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Electromagnetic navigation bronchoscopy-guided transbronchial dye marking for localization of peripheral lung lesions.

Otero, AP, Rafecas-Codern, A, Reyes, JCT, Tellez, EM, Mitja, PS, Brenes, JM, Nino, CAL, Canovas, GP, Colom, MN, Castosa, MV, Fernandez, AT. Electromagnetic navigation bronchoscopy-guided transbronchial dye marking for localization of peripheral lung lesions.. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1623. PMID:. IF:21.000(Q1/1D).

01/09/2024 Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis

Ballester-Servera, C, Alonso, J, Taurón, M, Rotllán, N, Rodríguez, C, Martínez-González, J. Lysyl oxidase expression in smooth muscle cells determines the level of intima calcification in hypercholesterolemia-induced atherosclerosis. Clinica E Investigacion En Arteriosclerosis. 2024; 36(5)DOI:10.1016/j.arteri.2024.01.003. PMID:38402026. IF:(Q/D).

01/09/2024 Estimating the Glomerular Filtration Rate in the Pediatric Intensive Care Unit: using the Kinetic equation

Devolder, A, Resa, JC, Casals, JT, Fernandez, EC, Martínez, MR, Gomez, FC, Compañó, AP, Sanagustín, SB, Boronat, S, Rodriguez, GMF. Estimating the Glomerular Filtration Rate in the Pediatric Intensive Care Unit: using the Kinetic equation. PEDIATRIC NEPHROLOGY. 2024; 39(1)DOI:. PMID:. IF:2.600(Q1/2D).

01/09/2024 Design and Interrater Reliability of the Pediatric Version of the Race Scale: PedRACE

Turón-Viñas, E, Boronat, S, Gich, I, Alvarez, VG, García-Puig, M, Carreras, MC, Rodriguez-Palmero, A, Felipe-Rucián, A, Aznar-Laín, G, Jiménez-Fàbrega, X, de la Ossa, NP. Design and Interrater Reliability of the Pediatric Version of the Race Scale: PedRACE. STROKE. 2024; 55(9)DOI:10.1161/STROKEAHA.124.046846. PMID:39051112. IF:8.900(Q1/1D).

01/09/2024 A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE)

Giorgi, S, Auvin, S, Schoonjans, AS, Turón, E, Sánchez-Miranda, I, Gil-Nagel, A, Lagae, L, Aibar, JA. A tool for Dravet syndrome-associated neuropsychiatric comorbidities evaluation (DANCE). EPILEPSY & BEHAVIOR. 2024; 158DOI:10.1016/j.yebeh.2024.109958. PMID:39067307. IF:2.300(Q2/4D).

01/09/2024 Role of Venous Delay on Stroke Outcome: Prospective Evaluation Before and After Mechanical Thrombectomy

Zangana, L, Valls, A, Munuera, J, Werner, M, Remollo, S, Dorado, L, Serena, J, Puig, J, de la Ossa, NP, Gomis, M, Bustamante, A, Pina, BF, Martinez, M, Castaño, C, Muñoz, L, Massuet, A, Coutinho, JM, Millán, M, Hernández-Pérez, M. Role of Venous Delay on Stroke Outcome: Prospective Evaluation Before and After Mechanical Thrombectomy. Journal of Stroke. 2024; 26(3)DOI:10.5853/jos.2024.00150. PMID:39223974. IF:8.600(Q1/1D).

01/09/2024 Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels

Ferre-Giraldo, A, Castells, M, Sánchez-Herrero, JF, López-Rodrigo, O, de Rocco-Ponce, M, Bassas, L, Vigués, F, Sumoy, L, Larriba, S. Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(18)DOI:10.3390/ijms251810122. PMID:39337607. IF:4.900(Q1/3D).

01/09/2024 Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease

Ben-Aicha, S, Anwar, M, Vilahur, G, Martino, F, Kyriazis, PG, de Winter, N, Punjabi, PP, Angelini, GD, Sattler, S, Emanueli, C. Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease. Jacc-Basic To Translational Science. 2024; 9(9)DOI:10.1016/j.jacbts.2024.05.003. PMID:39444932. IF:7.200(Q1/2D).

01/09/2024 Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study

de Isla, LP, Vallejo-Vaz, AJ, Watts, GF, Muñiz-Grijalvo, O, Alonso, R, Diaz-Diaz, JL, Arroyo-Olivares, R, Aguado, R, Argueso, R, Mauri, M, Romero, MJ, Alvarez-Baños, P, Mañas, D, Cepeda, JM, Gonzalez-Bustos, P, Casañas, M, Michan, A, Muñoz-Torrero, JFS, Faedo, C, Barba, MA, Dieguez, M, de Andrés, R, Hernandez, AM, Gonzalez-Estrada, A, Padró, T, Fuentes, F, Badimon, L, Mata, P. Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study. Lancet Diabetes & Endocrinology. 2024; 12(9)DOI:10.1016/S2213-8587(24)00192-X. PMID:39098315. IF:41.800(Q1/1D).

01/09/2024 Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis

Fernandez-Bravo, S, Canyelles, M, Martín-Blázquez, A, Borràs, C, Nuñez-Borque, E, Palacio-García, L, Del Rio, PR, Betancor, D, Gómez-López, A, Brescó, MS, Laguna, JJ, Méndez-Barbero, N, Rotllan, N, Escolà-Gil, JC, Esteban, V. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(3)DOI:10.1016/j.jaci.2024.03.031. PMID:38718948. IF:11.200(Q1/1D).

01/09/2024 Serum calprotectin in severe and mild COVID-19 patients

Agulló, GJ, Aragon, MP, de la Poza, JFD, Alcorisa, SV. Serum calprotectin in severe and mild COVID-19 patients. EUROPEAN JOURNAL OF IMMUNOLOGY. 2024; 54DOI:. PMID:. IF:3.700(Q2/5D).

01/09/2024 Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period

Somolinos-Simón, FJ, García-Sáez, G, Tapia-Galisteo, J, Corcoy, R, Hernando, ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 215DOI:10.1016/j.diabres.2024.111803. PMID:39089589. IF:7.400(Q1/1D).

01/09/2024 Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy

Cheng, A, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, M, Bonnemaire, M, Lydie, MM, Mimouni, S, Davies, M. Efficacy and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes with/without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

01/09/2024 Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation

Claramunt, FC, Lazaro, D, Salter, J, Paldánius, P, Mauricio, D. Non-invasive near-infrared system for screening for diabetes: first results from the ANODE03 clinical investigation. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

01/09/2024 Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study

Torre, ELM, Alarcón, PP, Rodríguez, MM, Serrallonga, NB, Palomar, JR, Iglesias, DM, Hoyas, CN, Servat, OS, Kyriakos, G, Bellas, LC, Pla, RC, Ramonde, TM, López, ML, Madorell, BS, Borrás, JG. Open-label, descriptive, sequential study in type 1 diabetes patients to evaluate the Mylife™-Dose app with ISCI and compare it to a hybrid continuous insulin infusion system (CamAPS): Dose Human Loop study. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

01/09/2024 Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects

Rosales, A, Gil, P, Julian, T, Teis, A, Pedraz, B, Sanchez, J, Julve, J, Mauricio, D, Perez, A, Alonso, N. Myocardial steatosis and improvement of cardiac function after glycaemic optimisation treatment in newly diagnosed type 2 diabetes subjects. DIABETOLOGIA. 2024; 67DOI:. PMID:. IF:10.200(Q1/1D).

01/09/2024 Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024)

Araujo-Castro, M, Biagetti, B, Torre, EM, Novoa-Testa, I, Cordido, F, Pascual-Corrales, E, Berrocal, VR, Guerrero-Perez, F, Vicente, A, Hualpa, JCP, Garcia-Centeno, R, Gonzalez-Fernandez, L, Garcia, MDO, Echarri, AI, Rodriguez, MDM, Novo-Rodriguez, C, Calatayud, M, Villar-Taibo, R, Bernabeu, I, Alvarez-Escola, C, Valderrama, PB, Tenorio-Jimenez, C, Galiana, PA, Venegas, E, Gonzalez-Molero, I, Iglesias, P, Blanco-Carrera, C, De Lara, FVO, Novoa, PD, Mezquita, EL, Hanzu, FA, Aldecoa, I, Aznar, S, Lamas, C, Aulinas, A, Asla, Q, Gimeno, PG, Recio-Cordova, JM, Aviles-Perez, MD, Asensio-Wandosell, D, Sampedro-Nunez, M, Camara, R, Fano, MP, Ruz-Caracuel, I, Fajardo, C, Marazuela, M, Puig-Domingo, M. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs (vol 31, e240043, 2024). ENDOCRINE-RELATED CANCER. 2024; 31(9)DOI:10.1530/ERC-24-0043e. PMID:. IF:4.600(Q1/3D).

01/09/2024 An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial

Ortiz, O, Daca-Alvarez, M, Rivero-Sanchez, L, Gimeno-Garcia, AZ, Carrillo-Palau, M, Alvarez, V, Ledo-Rodriguez, A, Ricciardiello, L, Pierantoni, C, Hüneburg, R, Nattermann, J, Bisschops, R, Tejpar, S, Huerta, A, Pons, FR, Alvarez-Urturi, C, López-Vicente, J, Repici, A, Hassan, C, Cid, L, Cavestro, GM, Romero-Mascarell, C, Gordillo, J, Puig, I, Herraiz, M, Betes, M, Herrero, J, Jover, R, Balaguer, F, Pellisé, M. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00187-0. PMID:39033774. IF:38.600(Q1/1D).

01/09/2024 Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors

Ollivier-Hourmand, I, Lebedel, L, Alabau, BB, Goria, O, Bureau, C, Dumortier, J, Heurgue, A, Silvain, C, De-Ledinghen, V, Rautou, PE, Payance, A, Ballester, TG, Alvarado-Tapias, E, Hernandez-Gea, V, Valla, D, Zekrini, K, Nguyen, TTN, Dao, T, Pagan, JCG, Morello, R, Plessier, A. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors. JOURNAL OF HEPATOLOGY. 2024; 81(3)DOI:10.1016/j.jhep.2024.04.016. PMID:38679069. IF:33.000(Q1/1D).

01/09/2024 Ultrasound in Rheumatology, It is a Must

Corominas, H, Badlissi, F. Ultrasound in Rheumatology, It is a Must. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.250324. PMID:39308354. IF:(Q/D).

01/09/2024 Ultrasound for the Diagnosis of Giant Cell Arteritis

Alarcón, PVE, Alvarado, PM, Alierta, ELS. Ultrasound for the Diagnosis of Giant Cell Arteritis. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2024.20104. PMID:39311386. IF:(Q/D).

01/09/2024 SSc-PAH patients are at risk of disease progression in contemporary clinical practice

Bjorkekjær, HJ, Bruni, C, Brunborg, C, Carreira, P, Airò, P, Simeón-Aznar, CP, Truchetet, ME, Giollo, A, Balbir-Gurman, A, Martin, M, Denton, CP, Gabrielli, A, Fretheim, H, Bitter, H, Midtvedt, O, Broch, K, Andreassen, A, Hoie, S, Tanaka, Y, Riemekasten, G, Müller-Ladner, U, Matucci-Cerinic, M, Castellví, I, Siegert, E, Hachulla, E, Molberg, O, Distler, O, Hoffmann-Vold, AM. SSc-PAH patients are at risk of disease progression in contemporary clinical practice. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2493. PMID:. IF:21.000(Q1/1D).

01/09/2024 ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis

De Miguel, E, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moya, P, Tortosa-Caba as, M, Navarro, VA, Calvet, J, Casafont-Sol , I, Rom n-Ivorra, JA, Labrada-Arrabal, S, Rocha, MV, I iguez, CL, Hern ndez-Hern ndez, V, Campos-Fern ndez, C, Villar, MA, Juan-Mas, A, Prado-Galbarro, FJ, Calvo, I, S nchez-Mart n, J, Narvaez-Garc a, J, Blanco-Alonso, R. ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study

Narvaez-Garc a, J, Llobell, A, Ponce, A, Gomez-Centeno, A, Mill n, AM, Corominas, H, Nolla, JM, Gomez-Puerta, JA. Clinical Patterns and Long-term Outcomes of Arthritis Triggered by Immune Checkpoint Inhibitors. A Multicenter Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient's Characteristics

Carri n-Barber , I, Monte, TCS, Triginer, L, Garc a-Villanueva, M, Corral, SG, Frutos, AR, Font, J, Galindo-Izquierdo, M, Polo, CDF, Gil, JJF, Moriano, C, Alvarez, ED, Bernab u, P, Vela-Casasempere, P, Cortes-Hern ndez, J, Moreno, SS, Narvaez-Garc a, J, Hern ndez-Mart n, A, Magallares, BP, Garc a, MP, Marras, C, Ramos, C, Gomez-Puerta, JA, Frade-Sosa, B, Fern ndez-Ortiz, A, Garcia-Aparicio, A, Altab s-Gonz lez, I, Hern ndez-Baldiz n, S, Ros-Vilamajo, I, Cirera, SG, Bufort, MG, Sala, L, Mart nez-Barrio, J, de Salazar, JRG, Heredia, S, Torrente-Segarra, V, Brandy-Garcia, AM, Del Amo, NDV, Fito-Manteca, C, Calvo-Alen, J, Pego-Reigosa, JM, R a-Figueroa, I. Ambispective, Multicenter Registry of Treatment with Anifrolumab in Real Life in Patients with Systemic Lupus Erythematosus from Spanish Rheumatology Departments (ANIFRO-Reu): Efficacy, Safety and Patient's Characteristics. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry

Narvaez-Garc a, J, Dominguez-Alvaro, M, Gal ndez-Agirregoikoa, E, Mendizabal, J, Alcazar, IA, Loricera, J, Garrido-Pu al, N, Casta eda, S, Moya, P, Larena, C, Estrada-Alarc n, P, Galisteo, C, Frutos, AR, Sanjuan, FO, Monte, TCS, Rocha, MV, Ubiaga, CLI, Garcia-Gonzalez, M, Blanco-Alonso, R. Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry

Fern ndez-Lozano, D, Dom nguez-Alvaro, M, Narvaez-Garc a, J, Garrido-Pu al, N, De Miguel, E, Estrada-Alarc n, P, Hern ndez-Rodr guez, I, Silva-Diaz, M, Belzunegui, JM, Moriano, C, S nchez-Mart n, J, Calvo, I, Aldasoro, V, Alcazar, LA, Loricera, J, Moya, P, Garc a-Villanueva, M, S nchez-Alonso, F, Casta eda, S, Hern ndez, JL, Blanco-Alonso, R. Sex Differences in Phenotypes and Imaging Examination in Giant Cell Arteritis: Data from the ARTESER Registry. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment

G mez, MLI, Escudero, PG, L pez, BM, Dorta, AG, Frade-Sosa, B, Lizarzaburu, MS, R a-Figueroa, I, Su rez, DVF, de Miera, FJTS, Melero-Gonzalez, RB, Santos, DD, Miranda, JA, Belando, CG, Boselli, G, Boteanu, AL, Selaya, CC, Santos, CS, Alvarez, ED, Font, J, Alonso, ER, Aragu s, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, G mez, IV, Vela-Casasempere, P, Merino, C, Mart nez, MI, Beriain, JAH, Roman, AMR, Calvo-Al n, J. Therapeutic Insights in VEXAS Syndrome from a Multicenter Study in Spain: Moving Towards Amore Specific and Effective Treatment. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study

Mysler, E, Ignatenko, S, Gordienko, A, Cort s-Hern ndez, J, Agmon-Levin, N, Narongroeknawin, P, Romanowska-Prochnicka, K, Shen, N, Cifersk , H, Kodera, M, Wei, JCC, Leszczynski, P, Lan, JL, Wojciechowski, R, Tarr, T, Vishneva, E, Chen, YH, Kaneko, Y, Finzel, S, Hoi, A, Okada, M, Koolvisoot, A, Lee, SS, Dai, L, Kaneko, H, Rojkovich, B, Sun, LY, Zotkin, E, Viallard, JF, Magallares, BP, Sengupta, T, Sips, C, Lau, C, Avrameas, A, Oliver, SJ. Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease

Zhang, YL, Tedeschi, S, Abhishek, A, Hensey, O, Grossberg, D, Cai, K, Shea, B, Singh, J, Christensen, R, Serban, T, Cipolletta, E, Parperis, K, D az, C, McCarthy, G, Becce, F, Gheita, TA, Sirotti, S, Christiansen, SN, Tarancon, LC, Stamp, L, Abdel-Fattah, YH, Pascart, T, Filippou, G, Hong, LE, FitzGerald, J, Dalbeth, N. Delphi Survey to Establish Consensus on the OMERACT Core Domain Set for Long-Term Studies of Calcium Pyrophosphate Deposition Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Effectiveness of Rituximab in IgG4 Related Disease

Lopez-Gutierrez, F, Loricera, J, Hormigos, C, Nu ez, DF, Rodriguez-Laguna, M, Albarado, PM, G mez, MLI, Corominas, H, Silva-D az, M, Arribas, GG, Garcia-Aparicio, A, Urgelles, JF, Casafont-Sole, I, Calabuig, PM, Castaneda, E, Merino, C, Zas, R, Molina-Collada, J, Melero-Gonzalez, RB, Galindez-Agirregoikoa, E, Hern ndez-Mart n, A, Pantoja, L, Abascal, IB, Jovani, V, Valls-Pascual, E, V zquez, NM, Gallego-Flores, A, Ra a, NC, Veroz, R, Andres, M, Casta eda, S, Blanco-Alonso, R. Effectiveness of Rituximab in IgG4 Related Disease. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis

Guerrero, MR, Moriano, C, Santos, CS, Herranz, LS, Garcia, JJ, Barranco, IC, Alvarez, ED. Evaluation of the New Criteria for Progressive Pulmonary Fibrosis in Patients with Systemic Sclerosis. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study

De Silva, C, D az, C, Gamble, G, Horne, A, Doyle, A, Stamp, L, Dalbeth, N. Mapping Monosodium Urate Crystal Deposition Within Joints in Tophaceous Gout: A Dual Energy CT Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases

Quevedo-Rodr guez, A, Otero-Varela, L, S nchez-Alonso, F, P rez-Vera, Y, Manero-Ruiz, J, Campos-Fern ndez, C, Manrique-Arija, S, Vela-Casasempere, P, Mera-Varela, A, D az, C, Movasat, A, Garcia-Magallon, B, Ros-Vilamaj , I, Perez-Garcia, C, Castrejon, I. Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort

D'Alessandro, R, Rodolfi, S, Calot, A, Bebear, L, Campochiaro, C, Codullo, V, Del Galdo, F, Barranco, IC, Zanatta, E, Randone, SB, Boleto, G, Raffray, L, Chatelus, E, Cacoub, P, Le Joncour, A, Airo, P, Santos, CS, Lescoat, A, Avouac, J, Denton, C, Allanore, Y. Features of Anti-Fibrillarin Positive Systemic Sclerosis Patients and Ethnic Differences: A European Multicenter Cohort. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study

Avil s, A, Plaza, Z, S nchez-Alonso, F, Casta eda, S, Fernandez-Gutierrez, B, D az, C, Font, P, Martinez, O, Giner, E, Senabre, JM, Rueda, A, Perez, A, Sanchez, G, Gonzalez, C, Garc a, J, Llorca, J, Gonzalez-Gay, MA, Andres, M. Prognostic Value of Hyperuricemia in Developing Cardiovascular Events in Patients with Chronic Inflammatory Arthritis: A 10-Year Prospective Study. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients

Escudero, PG, G mez, MLI, L pez, BM, Santos, DD, de Miera, FJTS, Dorta, AG, Beriain, JAH, R a-Figueroa, I, Santos, CS, Alvarez, ED, Mart nez, MI, Frade-Sosa, B, Urgelles, JF, Lizarzaburu, MS, Alonso, ER, Aragu s, ET, Merayo, EE, Rodriguez-Laguna, M, Monjo, I, Merino, C, Vela-Casasempere, P, G mez, IV, Filloy, JAM, Melero-Gonzalez, RB, Belando, CG, Boselli, G, Boteanu, AL, Su rez, DVF, Selaya, CC, Roman, AMR, Calvo-Al n, J. Phenotypical Differences in VEXAS Syndrome, Where Are We a Year Later? Results from a National Cohort Focused on Rheumatological Patients. Arthritis & Rheumatology. 2024; 76DOI:. PMID:. IF:10.900(Q1/1D).

01/09/2024 The Gut-Airways Microbiome axis in COPD

Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez, M, Miratlles, L, Quero, S, Willis, J, Saus, E, Gabaldón, T, Gea, J, Santos, MS, Agusti, A, Monsó, E, Sibila, O, Faner, R. The Gut-Airways Microbiome axis in COPD. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA3032. PMID:. IF:21.000(Q1/1D).

01/09/2024 Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC

Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemoelle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. Heterogeneity of comorbidities captured by European national severe asthma registries in SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1763. PMID:. IF:21.000(Q1/1D).

01/09/2024 Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma

Fouka, E, Bansal, AT, Jaun, F, Håkansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Leuppi, J, Louis, R, Oureiro, C, Lúoviksdóttir, D, Mihaltan, F, Popovic, SG, Ramos-Barbon, D, Sedlak, V, Sergejeva, S, Skrgat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Initial data analysis of the SHARP CRC patient population reveals a large heterogeneity among European patients with severe asthma. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA4008. PMID:. IF:21.000(Q1/1D).

01/09/2024 European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC

Rink, S, Freeman, A, Bansal, AT, Bossios, A, Frankemölle, B, Schleich, F, Sont, JK, Singh, M, Bieksiene, K, Bourdin, A, Canonica, GW, Csoma, Z, Gemicioglu, B, Grisle, I, Popovic, SG, Hromis, S, Korn, S, Kuna, P, Loureiro, C, Mihaltan, F, Porsbjerg, C, Ramos-Barbon, D, Renaud, L, Sergejeva, S, Ten Brinke, A, Yasinska, V, Zervas, E, Skrgat, S, Kurukulaaratchy, R. European physician perspectives on multimorbidity in severe asthma: findings from SHARP CRC. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2149. PMID:. IF:21.000(Q1/1D).

01/09/2024 Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study

Jaun, F, Bánsal, AT, Fouka, E, Hakansson, KEJ, Bieksiene, K, Bourdin, A, Butler, M, Canonica, GW, Csoma, Z, Dahlén, B, Gemicioglu, B, Grisle, I, Heaney, L, Heffler, E, Hromis, S, Kuna, P, Mihaltan, F, Leuppi, JD, Loureiro, C, Louis, R, Luoviksdóttir, D, Ramos-Barbon, D, Popovic, SG, Samitas, K, Sedlak, V, Sergejeva, S, Skrat, S, Ten Brinke, A, Yasinska, V, Zervas, E, Schleich, F, Porsbjerg, C, Bossios, A. Clinical characteristics of severe asthma patients in Europe, according to the percentage of GDP spent on healthcare- a SHARP-CRC study. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1248. PMID:. IF:21.000(Q1/1D).

01/09/2024 The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries

Bourdin, A, Bansal, AT, Di Matteo, S, Giacomo, CM, Heaney, B, Ten Brinke, A, Csoma, Z, Dahlen, B, Djukanovic, R, Heaney, L, Kuna, P, Heffler, E, Louis, R, Porsbjerg, C, Ramos-Barbon, D, Skrgat, S, Paulsson, T, Mascialino, B. The SHARP CRC Health Economics Study. Simulation of the preventable costs of oral corticosteroids in severe asthmatics in eleven European countries. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA1176. PMID:. IF:21.000(Q1/1D).

01/09/2024 Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation

Otero, ARP, Pujal, P, Rafecas, A, Panadero, C, Penacoba, P, Puy, C, Segura, M, Anton, PA. Stoma Stent in a traqueotomy decanulation process. Experience in a cohort of patients with prolongued mechanical ventilation. EUROPEAN RESPIRATORY JOURNAL. 2024; 64DOI:10.1183/13993003.congress-2024.PA2615. PMID:. IF:21.000(Q1/1D).